These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 12454767

  • 1. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P, Temam S, Charlotte F, Lacau-St-Guily J.
    Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767
    [Abstract] [Full Text] [Related]

  • 2. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000 Dec 02; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 3. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov 02; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R, Ciruelos E, Amador ML, Benito A, Sanchez JJ, Ballestin C, Cortes-Funes H.
    Eur J Cancer; 2005 Feb 02; 41(3):453-60. PubMed ID: 15691646
    [Abstract] [Full Text] [Related]

  • 5. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
    Giatromanolaki A, Koukourakis M, Zaramboukas T, Skordalaki A, Arapantoni P, Georgoulias V, Fountzilas G.
    Anticancer Res; 1998 Feb 02; 18(6B):4685-92. PubMed ID: 9891541
    [Abstract] [Full Text] [Related]

  • 6. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2005 Feb 02; 25(4):2749-55. PubMed ID: 16080521
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M, Cullen KJ.
    Clin Cancer Res; 1999 Dec 02; 5(12):4097-104. PubMed ID: 10632346
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.
    Sauter ER, Ridge JA, Litwin S, Langer CJ.
    Clin Cancer Res; 1995 Nov 02; 1(11):1407-12. PubMed ID: 9815938
    [Abstract] [Full Text] [Related]

  • 9. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, Sanchez-Cespedes M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8486-92. PubMed ID: 15623629
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct 15; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 11. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
    Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M.
    Laryngoscope; 2002 Apr 15; 112(4):638-44. PubMed ID: 12150516
    [Abstract] [Full Text] [Related]

  • 12. Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma.
    Handra-Luca A, Hernandez J, Mountzios G, Taranchon E, Lacau-St-Guily J, Soria JC, Fouret P.
    Clin Cancer Res; 2007 Jul 01; 13(13):3855-9. PubMed ID: 17606717
    [Abstract] [Full Text] [Related]

  • 13. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 01; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 15. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck.
    Temam S, Flahault A, Périé S, Monceaux G, Coulet F, Callard P, Bernaudin JF, St Guily JL, Fouret P.
    J Clin Oncol; 2000 Jan 12; 18(2):385-94. PubMed ID: 10637254
    [Abstract] [Full Text] [Related]

  • 16. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.
    Br J Cancer; 2000 Nov 12; 83(10):1380-6. PubMed ID: 11044365
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y.
    Clin Cancer Res; 1999 Apr 12; 5(4):801-6. PubMed ID: 10213215
    [Abstract] [Full Text] [Related]

  • 18. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P, Adelstein DJ, Myles J, Secic M.
    Laryngoscope; 2001 Nov 12; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [Abstract] [Full Text] [Related]

  • 19. p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy.
    Warnakulasuriya S, Jia C, Johnson N, Houghton J.
    J Pathol; 2000 May 12; 191(1):33-8. PubMed ID: 10767716
    [Abstract] [Full Text] [Related]

  • 20. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
    Seitz JF, Perrier H, Monges G, Giovannini M, Gouvernet J.
    Gastroenterol Clin Biol; 1995 May 12; 19(5):465-74. PubMed ID: 7589997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.